Literature DB >> 9766532

Intracellular signaling of osteogenic protein-1 through Smad5 activation.

K Tamaki1, S Souchelnytskyi, S Itoh, A Nakao, K Sampath, C H Heldin, P ten Dijke.   

Abstract

Smad proteins play pivotal roles in the intracellular signaling of the multifunctional transforming growth factor-beta (TGF-beta) family members downstream of serine/threonine kinase type I and type II receptors. Smad2 and Smad3 are specific mediators of TGF-beta and activin, while Smadl and Smad5 are involved in bone morphogenetic protein-2 (BMP-2) and BMP-4 signaling. Here we report that osteogenic protein-1 (OP-1), also termed BMP-7, binds predominantly to BMPR-IB in the rat osteoprogenitor-like cell line, ROB-C26. Smad1, Smad5, and Smad8, but not Smad2 and Smad3, were found to stably interact with the kinase-deficient BMPR-IB after it was phosphorylated by the BMPR-II kinase. In ROB-C26 cells, which express Smad2, Smad3, Smad4, and Smad5, OP-1 was found to stimulate the phosphorylation of Smad5. Whereas transfection of wild-type Smad5 enhanced the OP-1-induced response, transfection of wild-type Smad2 had no effect on OP-1 signaling. A Smad5-2SA mutant, in which the two most carboxy-terminal serine residues were mutated to alanine residues, was found to act as a dominant negative inhibitor of OP-1-induced responses upon its transfection into various cell types, including ROB-C26 cells, in contrast to ectopic expression of a Smad2-2SA mutant which was without effect. Smad5, therefore, is a key component in the intracellular signaling of OP-1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9766532     DOI: 10.1002/(SICI)1097-4652(199811)177:2<355::AID-JCP17>3.0.CO;2-8

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

1.  Expression of growth differentiation factor-5 and bone morphogenic protein-7 in intraocular osseous metaplasia.

Authors:  S Toyran; A Y Lin; D P Edward
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

2.  Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.

Authors:  F Itoh; H Asao; K Sugamura; C H Heldin; P ten Dijke; S Itoh
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

3.  Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.

Authors:  Marie-José Goumans; Gudrun Valdimarsdottir; Susumu Itoh; Alexander Rosendahl; Paschalis Sideras; Peter ten Dijke
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

4.  Effects of bone morphogenetic protein-2 and transforming growth factor beta1 on gene expression of transcription factors, AJ18 and Runx2 in cultured osteoblastic cells.

Authors:  Minoru Takagi; Naoko Kamiya; Tomihisa Takahashi; Shinsuke Ito; Mitsuharu Hasegawa; Naoto Suzuki; Koji Nakanishi
Journal:  J Mol Histol       Date:  2004-01       Impact factor: 2.611

5.  Podocyte-derived BMP7 is critical for nephron development.

Authors:  Itsuro Kazama; Zhen Mahoney; Jeffrey H Miner; Daniel Graf; Aris N Economides; Jordan A Kreidberg
Journal:  J Am Soc Nephrol       Date:  2008-10-15       Impact factor: 10.121

6.  Smad7 and protein phosphatase 1alpha are critical determinants in the duration of TGF-beta/ALK1 signaling in endothelial cells.

Authors:  Gudrun Valdimarsdottir; Marie-José Goumans; Fumiko Itoh; Susumu Itoh; Carl-Henrik Heldin; Peter ten Dijke
Journal:  BMC Cell Biol       Date:  2006-03-29       Impact factor: 4.241

7.  Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas.

Authors:  Jerome Fortin; Ruxiao Tian; Ida Zarrabi; Graham Hill; Eleanor Williams; Gonzalo Sanchez-Duffhues; Midory Thorikay; Parameswaran Ramachandran; Robert Siddaway; Jong Fu Wong; Annette Wu; Lorraine N Apuzzo; Jillian Haight; Annick You-Ten; Bryan E Snow; Andrew Wakeham; David J Goldhamer; Daniel Schramek; Alex N Bullock; Peter Ten Dijke; Cynthia Hawkins; Tak W Mak
Journal:  Cancer Cell       Date:  2020-03-05       Impact factor: 31.743

8.  A Process for the Design and Development of Novel Bone Morphogenetic Protein-7 (BMP-7) Mimetics With an Example: THR-184.

Authors:  William D Carlson; Peter C Keck; Dattatreyamurty Bosukonda; Frederic Roy Carlson
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

9.  Diverse bone morphogenetic protein expression profiles and smad pathway activation in different phenotypes of experimental canine mammary tumors.

Authors:  Helena Wensman; Nils-Erik Heldin; Gunnar Pejler; Eva Hellmén
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

10.  BMP7 expression correlates with secondary drug resistance in mantle cell lymphoma.

Authors:  Valérie Camara-Clayette; Serge Koscielny; Sébastien Roux; Thierry Lamy; Jacques Bosq; Marc Bernard; Thierry Fest; Vladimir Lazar; Gilbert Lenoir; Vincent Ribrag
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.